| Christopher Zixiang Zheng, MD | |
|
200 1st St Sw, Rochester, MN 55905-0002 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Christopher Zixiang Zheng |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 6 Years |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285130005 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 71087 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
News Archive
Merck KGaA and Dyesol Limited have signed an agreement to collaborate in the development of electrolytes for use in Dye Solar Cells (DSC).
LSU Professor and Patrick F. Taylor Chair of Chemistry Barry Dellinger was recently awarded a grant of $3.6 million by the National Institute of Environmental Health Sciences, or NIEHS, to support a Superfund Research Center focusing on hazardous waste disposal and its impact on public health. It is the only center ever awarded by this program that is not located at a medical school or school of public health.
WHO today listed the nOPV2 vaccine (Bio Farma, Indonesia) for emergency use to address the rising cases of a vaccine-derived polio strain in a number of African and East Mediterranean countries.
Research led by Howard L. Kaufman, MD, FACS, associate director for clinical science and chief surgical officer at Rutgers Cancer Institute of New Jersey and colleagues, shows advanced-stage melanoma patients have significant improvement in durable response rate and a trend toward improved survival when treated with a genetically-modified form of a herpes virus, whose native form causes the common cold sore.
› Verified 9 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Merck KGaA and Dyesol Limited have signed an agreement to collaborate in the development of electrolytes for use in Dye Solar Cells (DSC).
LSU Professor and Patrick F. Taylor Chair of Chemistry Barry Dellinger was recently awarded a grant of $3.6 million by the National Institute of Environmental Health Sciences, or NIEHS, to support a Superfund Research Center focusing on hazardous waste disposal and its impact on public health. It is the only center ever awarded by this program that is not located at a medical school or school of public health.
WHO today listed the nOPV2 vaccine (Bio Farma, Indonesia) for emergency use to address the rising cases of a vaccine-derived polio strain in a number of African and East Mediterranean countries.
Research led by Howard L. Kaufman, MD, FACS, associate director for clinical science and chief surgical officer at Rutgers Cancer Institute of New Jersey and colleagues, shows advanced-stage melanoma patients have significant improvement in durable response rate and a trend toward improved survival when treated with a genetically-modified form of a herpes virus, whose native form causes the common cold sore.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Zixiang Zheng, MD 200 1st St Sw, Rochester, MN 55905-0002 Ph: (507) 284-2511 | Christopher Zixiang Zheng, MD 200 1st St Sw, Rochester, MN 55905-0002 Ph: (507) 284-2511 |
News Archive
Merck KGaA and Dyesol Limited have signed an agreement to collaborate in the development of electrolytes for use in Dye Solar Cells (DSC).
LSU Professor and Patrick F. Taylor Chair of Chemistry Barry Dellinger was recently awarded a grant of $3.6 million by the National Institute of Environmental Health Sciences, or NIEHS, to support a Superfund Research Center focusing on hazardous waste disposal and its impact on public health. It is the only center ever awarded by this program that is not located at a medical school or school of public health.
WHO today listed the nOPV2 vaccine (Bio Farma, Indonesia) for emergency use to address the rising cases of a vaccine-derived polio strain in a number of African and East Mediterranean countries.
Research led by Howard L. Kaufman, MD, FACS, associate director for clinical science and chief surgical officer at Rutgers Cancer Institute of New Jersey and colleagues, shows advanced-stage melanoma patients have significant improvement in durable response rate and a trend toward improved survival when treated with a genetically-modified form of a herpes virus, whose native form causes the common cold sore.
› Verified 9 days ago
Emily Leasure, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Jorge A Velosa, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michael Ruediger Mueller, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mr. Karun Singh Badwal, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michal Reid, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Katherine Desprez Wick, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Allison Bock, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |